Health Enterprise Partners Announces Partner Promotion – Ezra Mehlman Promoted to Managing Partner

By | News

Health Enterprise Partners (“HEP”), a healthcare private equity fund, is pleased to announce the promotion of Ezra Mehlman to Managing Partner. “Ezra has demonstrated the energy, impeccable judgment, and character that are foundational to our firm and its investors,” said Dave Tamburri, Managing Partner of HEP. “We are confident that he will continue to make a significant contribution to the ongoing success of our firm.”

Mehlman joined HEP full-time in 2012 after interning at the firm for two years while attending Columbia Business School. Prior to HEP, he worked for the Advisory Board Company and Booz Allen Hamilton. Ezra serves on the boards of AxiaMed, CenterPointe Behavioral Health System, InDemand Interpreting, Jvion and Wildflower Health. He also served as a director of Applied Pathways prior to its acquisition by AIM Specialty Health, a division of Anthem, Inc. He is a member of HEP’s investment committee. Read More

Jvion Secures Significant Strategic Growth Investment to Expand Application of Its Healthcare AI and Prescriptive Analytics Platform

By | News

Investment will help meet surging healthcare demand for an AI-driven clinical decision support solution that improves patient outcomes, lowers the cost of care, and addresses challenges across various healthcare market segments.

(Atlanta, GA) Jvion, the market leader in healthcare AI, announced today that it raised a significant growth equity investment led by JMI Equity (JMI)—a growth equity firm focused on investing in leading software companies. Additional investors in the fundraise include Health Enterprise Partners (HEP) and Health Velocity Capital (HVC), two leading healthcare investment firms whose limited partner networks comprise some of the largest hospital systems and health plans in the country. Read More

Bardy Diagnostics™ Selected As Winner Of The Fierce Innovation Life Sciences Award

By | News

SEATTLE, Dec. 17, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today that it has been selected as a winner in the sixth annual Fierce Innovation Awards: Life Sciences Edition, an awards program from the leading industry publisher of FierceBiotech and FiercePharma aimed at identifying and showcasing outstanding innovations driving improvements and transformation in the digital health, biotech, and pharma industries. BardyDx earned top honors for the Carnation Ambulatory Monitor (“CAM™”), the world’s first P-wave centric™ ambulatory cardiac patch monitor and arrhythmia detection device. Read More

California Moms and Babies to Benefit From New, Enhanced Mobile Health Apps

By | News

Collaboration between Wildflower, Care1st (Blue Shield of California Promise Health Plan effective 1/1/19), an affiliate of Blue Shield, and the California Health Care Foundation extends critical health knowledge to Medi-Cal beneficiaries

Mothers and babies across California are about to experience a new level of support thanks to a unique collaboration that puts vital health education resources right at their fingertips. The initiative between Wildflower Health, Care1st Health Plan (Blue Shield of California Promise Health Plan effective 1/1/19), an affiliate of Blue Shield of California, and the California Health Care Foundation (CHCF) is designed to ensure that Medi-Cal families have access to the information they need to make important decisions about their health care. Read More

New Cigna Pregnancy App Enables Improved Health and Lower Costs For Pregnant Women

By | News

BLOOMFIELD, Conn. – Global health service company Cigna launched the new Cigna Healthy Pregnancy app to better connect individual customers to Cigna’s suite of health benefits including the Cigna Healthy Pregnancies, Healthy Babies maternity health engagement program. The Cigna Healthy Pregnancies, Healthy Babies program has shown to positively impact health outcomes for pregnant women and their babies. Read More

Bardy Diagnostics™ Selected as a Winner of the Children’s National Pediatric Medical Device Innovation Competition

By | News

SEATTLE, Sept. 26, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the world’s first P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device, announced it was selected as one of six winners of the “Make Your Medical Device Pitch for Kids!” Competition hosted by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System.

Eleven finalists from a field of 45 worldwide submissions were selected to present their products this past weekend at the Sixth Annual Pediatric Device Innovation Symposium. A distinguished judging panel of industry experts awarded BardyDx a $25,000 prize based on the CAM patch’s pediatric-friendly design, innovative P-wave centric technology, and potential to address significant unmet needs in pediatric healthcare. Read More

Wildflower Expands Family Health Platform to Comprehensively Support First 1,000 Days

By | News

Wildflower Health, a leading mobile health software company, today announced it has launched enhanced capabilities to support new parents during the critical first 1,000 days. Building on the strength of its maternity programming, Wildflower’s Family Health platform can now support parents as they manage the health needs of their newborns and their entire family during early childhood.

Countless research studies have documented the importance of the first 1,000 days, from conception until a child’s second birthday. Without a strong support system, issues stemming from malnutrition and undetected developmental delays can have a negative and irreversible impact that lasts a lifetime. Read More

Sign up to receive the HEP Newsletter